Emerging Innovative Therapeutic Approaches Leveraging Cyclin‐Dependent Kinase Inhibitors to Treat Advanced Breast Cancer-Reference-Cited by-同舟云学术

Emerging Innovative Therapeutic Approaches Leveraging Cyclin‐Dependent Kinase Inhibitors to Treat Advanced Breast Cancer

Published:2018-01-30 Issue:6 Volume:103 Page:1009-1019
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Cruz Marcelo¹,Reinert Tomás²,Cristofanilli Massimo³

Affiliation:

1. Developmental Therapeutics Division of Hematology OncologyNorthwestern University Feinberg School of MedicineChicago Illinois USA

2. Medical Science Post Graduation DepartmentUniversidade Federal do Rio Grande do SulPorto Alegre Brazil

3. Department of Medicine‐Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of MedicineNorthwestern UniversityChicago Illinois USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.965

Reference92 articles.

1. Breast Cancer Mortality Trends in the United States According to Estrogen Receptor Status and Age at Diagnosis

2. Endocrine Therapy for Hormone Receptor Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Summary

3. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

4. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States

5. 1st International consensus guidelines for advanced breast cancer (ABC 1)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lack of access to CDK4/6 inhibitors for premenopausal patients with metastatic breast cancer in Brazil: estimation of the number of premature deaths;ecancermedicalscience;2020-07-30

2. Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy;Molecules;2019-12-15

3. Molecular Mechanisms of Endocrine Resistance;Estrogen Receptor and Breast Cancer;2018-10-17

4. Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers;Frontiers in Oncology;2018-08-08

5. Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer;Chinese Clinical Oncology;2018-06